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Mutations in the BRCA1 and BRCA2 genes predispose
women to breast and ovarian cancer. The large majority
of the alterations identified in these genes are point
mutations and small insertion/deletion. However, an
increasing number of large genomic rearrangements are
being identified, especially in BRCA1. To date 161 and
39 gene alterations have been described in the literature,
approximately for BRCA1 and BRCA2. Just few large
genomic rearrangements of BRCA1 gene have been
reported in Poland.
Technical limitations of conventional PCR-based
methods are cause that gross rearrangements can be
overlooked. It has been suggest that about 30% of muta-
tions in the BRCA1 gene are missed by standard muta-
tion detection methods. We use Multiplex Ligation-
dependent Probe Amplification (MLPA) to analyze
BRCA1/2 rearrangements in 300 unrelated patients with
strong family history of breast and/or ovarian cancer
negative for BRCA1 Polish founder mutation.
The purpose of this study is establish the prevalence
of BRCA1 and BRCA2 large genomic rearrangements in
patients with hereditary breast and/or ovarian cancer of
Polish population.
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